Intended for healthcare professionals

Obituaries

Humphry Osmond

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7441.713 (Published 18 March 2004) Cite this as: BMJ 2004;328:713

Psychiatrist who investigated LSD, “turned on” Aldous Huxley, and coined the word “psychedelic”

Humphry Osmond was at the cutting edge of psychiatric research in the 1950s. He believed that hallucinogenic drugs might be useful in treating mental illness and he studied the effects of LSD on people with alcohol dependency. His investigations led to his association with the novelist Aldous Huxley and to involvement with the CIA and MI6, which were interested in LSD as a possible “truth drug” to make enemy agents reveal secrets.

Was Osmond ahead of his time? His work was cut short by the 1960s drugs backlash, and only now is his work with hallucinogens being looked at with new interest.

Humphry Osmond was born in Surrey in 1917 and graduated from Guy's Hospital Medical School. During the second world war he served in the navy as a ship's psychiatrist. After the war, at St George's Hospital, he and Dr John Smythies learnt of the chemist Albert Hofmann's work with the hallucinogenic drug LSD-25 in Switzerland. They thought schizophrenia might be caused by metabolic aberrations producing symptoms similar to those from drugs such as LSD and mescaline.

“Osmond was interested in a metabolic redefinition of schizophrenia as something like diabetes,” said a former colleague, California psychiatrist Dr Tod Hiro Mikuriya.

LSD-25 had been synthesized by Hofmann in 1938; he discovered its hallucinogenic properties in 1943. One day when he worked with the chemical he felt restless and dizzy and went home. Over the next few hours he experienced fantastic, vivid images with intense colours. He thought he had probably absorbed a small amount of the chemical.

During the 1940s and 1950s both scientists and government intelligence agencies were interested in using hallucinogenic drugs such as mescaline and LSD as a “truth drug”.

Osmond, the scientist, thought the hallucinogens might help treat mental illness. He later wrote, “Schizophrenics are lonely because they cannot let their fellows know what is happening to them and so lose the thread of social support. LSD-25, used as a psychotomimetic, allows us to study these problems of communication from the inside and learn how to devise better methods of helping the sick.” Some psychiatrists thought they should take LSD to understand what their patients were experiencing.


Embedded Image

Credit: BETTMAN/CORBIS

The psychiatric establishment was not interested in drugs. In 1951 Osmond moved to Canada, to a bleak institution called the Weyburn Mental Hospital in Saskatchewan, where he had good research funding from the Canadian government and the Rockefeller Foundation and worked with a biochemist colleague, Dr Abram Hoffer. The hospital had many alcoholic patients who had not responded to all previous treatments. Osmond thought that hallucinogenic drugs produced symptoms similar to delirium tremens. Producing a terrifying artificial delirium might frighten an alcoholic into change. Between 1954 and 1960, Osmond and Hoffer treated about 2000 alcoholics under carefully controlled conditions.

They were astonished by what they found. In an interview with the psychiatrist Dr John Halpern, associate director of the substance abuse research programme at Harvard's McClean Hospital, Dr Hoffer recalled, “Many of them didn't have a terrible experience. In fact, they had a rather interesting experience.” Osmond and Hoffer reported that 40% to 45% of the alcoholics who were treated with LSD had not returned to drinking after a year.

Osmond sought a name for the effect that LSD has on the mind, consulting the novelist Aldous Huxley who was interested in these drugs. Osmond and Huxley had become friends and Osmond gave him mescaline in 1953. Huxley suggested “phanerothyme,” from the Greek words for “to show” and “spirit,” and sent a rhyme: “To make this mundane world sublime, Take half a gram of phanerothyme.” Instead, Osmond chose “psychedelic,” from the Greek words psyche (for mind or soul) and deloun (for show), and suggested, “To fathom Hell or soar angelic/Just take a pinch of psychedelic.” He announced it at the New York Academy of Sciences meeting in 1957.

But the climate was changing in the cultural and political turmoil of the Swinging Sixties. The use of marijuana and other recreational drugs among young people was thought to be a cause of social unrest, environmental protests, women's lib, civil rights marches, and protests against the Vietnam war. “The money dried up,” said Dr Halpern, and new laws restricted researchers' ability to study the drugs. “Osmond was at the cutting edge of psychiatric research at the time. It was a tragedy his work was shut down because of the culture,” said Dr Charles Grob, professor of psychiatry at the University of California School of Medicine-Los Angeles (UCLA).

Osmond moved to head the Bureau of Research in Neurology and Psychiatry at the New Jersey Psychiatric Institute in Princeton. His colleague Dr Mikuriya, later in charge of marijuana research at the National Institute of Mental Health, was puzzled that Osmond and his colleagues had psychedelic drugs available in their offices when local police had undercover agents searching for drug users. He found the answer 20 years later when the book Acid Dreams revealed Osmond's CIA and MI6 connections.

Osmond later moved to the University of Alabama, where he was professor of psychology until his retirement in 1992. He leaves a wife, three children, and five grandchildren.

Humphry Fortescue Osmond, psychiatrist and researcher, former professor of psychology University of Alabama, United States (b Surrey, United Kingdom, 1917; q Guy's Hospital Medical School 1942), died from a cardiac arrhythmia on 6 February 2004.

[Janice Hopkins Tanne]

View Abstract